Position in OGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,723,463
+$3,779,852 QoQ
Shares Held
496,563
+1.0% QoQ
Ownership
0.189%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#68
of 626 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $4,800,494,597 across 17 Drug Manufacturers - General names. OGN ranks #10 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,333,307 | $1,599,208,548 | |
| 2 | JNJ |
Johnson & Johnson
|
3,780,752 | $960,197,585 | |
| 3 | ABBV |
AbbVie Inc.
|
2,733,648 | $687,895,182 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,809,518 | $489,523,063 | |
| 5 | AMGN |
Amgen Inc
|
904,954 | $327,701,942 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,051,819 | $259,226,812 | |
| 7 | PFE |
Pfizer Inc
|
8,609,603 | $207,319,240 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,347,347 | $192,874,134 |
All Filings in OGN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,723,463 | 496,563 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,943,611 | 491,421 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,373,929 | 470,562 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,006,250 | 468,750 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $4,636,923 | 479,021 | Shares | Sole | 2025-08-12 | |
| 2024-09-30 | $10,046,253 | 525,157 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $10,926,060 | 527,829 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $10,229,850 | 544,141 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $8,326,641 | 577,437 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $7,802,208 | 449,436 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $9,485,614 | 455,820 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $10,851,657 | 461,380 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $12,492,251 | 447,270 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,077,912 | 430,680 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $13,940,100 | 413,040 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $12,905,482 | 369,467 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $11,876,931 | 390,047 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $12,500,695 | 381,235 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $11,647,648 | 384,919 | Shares | Sole | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||